The shelf going effective opens the door for selling stockholders, including insiders, to exit their positions. With the company burning cash and expressing going-concern doubt, expect persistent overhang and likely further price pressure. Monitor for a prospectus supplement indicating an actual takedown.
Price Chart
Executive Summary
The SEC declared effective Serina Therapeutics' S-3 shelf registration (File No. 333-296166) on June 3, 2026. This shelf, filed 13 days ago, registers up to 16,450,442 shares of common stock for resale by selling stockholders, stemming from a $21.2M PIPE in March/April 2026. With ~15M shares outstanding, potential dilution exceeds 100%, and the company disclosed substantial doubt about its ability to continue as a going concern in its most recent 10-Q.
Key Facts
- Effectiveness date: June 3, 2026 for S-3 File No. 333-296166
- Registration covers up to 16,450,442 shares for resale by selling stockholders
- Shares originate from a $21.2M PIPE completed in March/April 2026
- Approximately 14,997,505 shares currently outstanding — potential dilution exceeds 100%
- Company disclosed substantial doubt about going concern in its most recent 10-Q (net loss -$6.9M in Q1 2026 vs -$4.8M in Q1 2025)
- Selling stockholders include insider Dr. Gregory H. Bailey
Financial Impact
Potential dilution of over 100% on current ~15M shares outstanding via up to 16.45M registered shares for resale
Risk Factors
- Massive dilution overhang with >100% potential share count increase
- Insider selling pressure from PIPE participants including Dr. Gregory H. Bailey
- Going-concern risk highlighted in recent 10-Q with widening net losses
- Low market cap ($27M) amplifies impact of any secondary sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001872 |
| Document: 9999999995-26-001872-index.html | 9999999995-26-001872 |
| Document: 9999999995-26-001872.txt | 9999999995-26-001872 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 6w ago | 8-K | $2.57 $2.16 | ▼ −15.95% | ▼ −14.86% | $1.71 (−33.46%) |
Jul 23, 2026 13w ago | Press Release | $2.09 $2.04 | ▼ −2.39% | ▼ −2.87% | $1.71 (−18.18%) |
Jul 22, 2026 13w ago | 8-K | $2.09 $2.04 | ▼ −2.39% | ▼ −2.87% | $1.71 (−18.18%) |
Jun 4, 2026 20w ago | EFFECT | $1.86 $1.81 | ▲ +2.69% | ▲ +0.14% | $1.71 (+8.06%) |
May 26, 2026 21w ago | Insider Cluster | $1.80 $1.79 | ▼ −0.56% | ▼ −1.02% | $1.71 (−5.00%) |
May 26, 2026 21w ago | Insider Cluster | $1.80 $1.79 | ▲ +0.56% | ▲ +1.02% | $1.71 (+5.00%) |
May 22, 2026 22w ago | S-3 | $1.92 $1.81 | ▲ +5.73% | ▲ +6.81% | $1.71 (+10.94%) |
Mar 27, 2026 30w ago | 10-K/A | $2.27 $2.15 | ▼ −5.29% | ▼ −9.15% | $1.71 (−24.67%) |
Mar 25, 2026 30w ago | Press Release | $2.61 $2.12 | ▼ −18.77% | ▼ −20.41% | $1.71 (−34.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers